Hortobagyi GN - Search Results

1

Gene expression profiles obtained from fine-needle aspirations of breast cancer reliably identify routine prognostic markers and reveal large-scale molecular differences between estrogen-negative and estrogen-positive tumors.

Pusztai L, Ayers M, Stec J, Clark E, Hess K, Stivers D, Damokosh A, Sneige N, Buchholz TA, Esteva FJ, Arun B, Cristofanilli M, Booser D, Rosales M, Valero V, Adams C, Hortobagyi GN, Symmans WF. Pusztai L, et al. Among authors: hortobagyi gn. Clin Cancer Res. 2003 Jul;9(7):2406-15. Clin Cancer Res. 2003. PMID: 12855612

2

Treatment of locally advanced breast cancer.

Booser DJ, Hortobagyi GN. Booser DJ, et al. Among authors: hortobagyi gn. Semin Oncol. 1992 Jun;19(3):278-85. Semin Oncol. 1992. PMID: 1609294 Review.

3

Ki-67 immunostaining in node-negative stage I/II breast carcinoma. Significant correlation with prognosis.

Sahin AA, Ro J, Ro JY, Blick MB, el-Naggar AK, Ordonez NG, Fritsche HA, Smith TL, Hortobagyi GN, Ayala AG. Sahin AA, et al. Among authors: hortobagyi gn. Cancer. 1991 Aug 1;68(3):549-57. doi: 10.1002/1097-0142(19910801)68:3<549::aid-cncr2820680318>3.0.co;2-j. Cancer. 1991. PMID: 1648433

4

Comparison of immunocytochemical and biochemical assays for estrogen receptor in fine needle aspirates and histologic sections from breast carcinomas.

Katz RL, Patel S, Sneige N, Fritsche HA Jr, Hortobagyi GN, Ames FC, Brooks T, Ordonez NG. Katz RL, et al. Among authors: hortobagyi gn. Breast Cancer Res Treat. 1990 May;15(3):191-203. doi: 10.1007/BF01806356. Breast Cancer Res Treat. 1990. PMID: 1695528

5

Clinical course of patients with breast cancer with ten or more positive nodes who were treated with doxorubicin-containing adjuvant therapy.

Buzdar AU, Kau SW, Hortobagyi GN, Ames FC, Holmes FA, Fraschini G, Hug V, Theriault RL, McNeese MD, Singletary SE. Buzdar AU, et al. Among authors: hortobagyi gn. Cancer. 1992 Jan 15;69(2):448-52. doi: 10.1002/1097-0142(19920115)69:2<448::aid-cncr2820690229>3.0.co;2-k. Cancer. 1992. PMID: 1728373

6

Measurement of estrogen and progesterone receptors in human breast tumors: enzyme immunoassay versus binding assay.

Holmes FA, Fritsche HA, Loewy JW, Geitner AM, Sutton RC, Buzdar AU, Hortobagyi GN. Holmes FA, et al. Among authors: hortobagyi gn. J Clin Oncol. 1990 Jun;8(6):1025-35. doi: 10.1200/JCO.1990.8.6.1025. J Clin Oncol. 1990. PMID: 2189952

7

Pregnancy and offspring after adjuvant chemotherapy in breast cancer patients.

Sutton R, Buzdar AU, Hortobagyi GN. Sutton R, et al. Among authors: hortobagyi gn. Cancer. 1990 Feb 15;65(4):847-50. doi: 10.1002/1097-0142(19900215)65:4<847::aid-cncr2820650402>3.0.co;2-a. Cancer. 1990. PMID: 2297653

8

Treatment of estrogen receptor-negative or hormonally refractory breast cancer with double high-dose chemotherapy intensification and bone marrow support.

Dunphy FR, Spitzer G, Buzdar AU, Hortobagyi GN, Horwitz LJ, Yau JC, Spinolo JA, Jagannath S, Holmes F, Wallerstein RO, et al. Dunphy FR, et al. Among authors: hortobagyi gn. J Clin Oncol. 1990 Jul;8(7):1207-16. doi: 10.1200/JCO.1990.8.7.1207. J Clin Oncol. 1990. PMID: 2358837 Clinical Trial.

9

Sequential cyclic combined hormonal therapy for metastatic breast cancer.

Hortobagyi GN, Hug V, Buzdar AU, Kau SW, Holmes FA, Fritsche HA. Hortobagyi GN, et al. Cancer. 1989 Sep 1;64(5):1002-6. doi: 10.1002/1097-0142(19890901)64:5<1002::aid-cncr2820640505>3.0.co;2-b. Cancer. 1989. PMID: 2527085

10

Ductal carcinoma-in-situ of the breast: fine-needle aspiration cytology of 12 cases.

Sneige N, White VA, Katz RL, Troncoso P, Libshitz HI, Hortobagyi GN. Sneige N, et al. Among authors: hortobagyi gn. Diagn Cytopathol. 1989;5(4):371-7. doi: 10.1002/dc.2840050406. Diagn Cytopathol. 1989. PMID: 2558863

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,102 results

Search Page